UNDISCLOSED
Exclusive Financial Advisor
Sale to Syncona
Pending
UNDISCLOSED
Exclusive Financial Advisor and Placement Agent
Merger with Homology Medicines & Concurrent $42M Private Placement
Pending
UNDISCLOSED
Exclusive Financial Advisor
Merger with LENZ Therapeutics
Pending
UNDISCLOSED
Exclusive Financial Advisor and Placement Agent
Merger with Cartesian Therapeutics and Concurrent Private Financing
November 2023
$200 Million
Joint Bookrunner
Follow-On
November 2023
$150 Million
Joint Bookrunner
Follow-On
November 2023
$99 Million
Joint Bookrunner
Follow-On
November 2023
$100 Million
Joint Bookrunner
Initial Public Offering
November 2023
$30 Million
Global Coordinator and Joint Bookrunner
Follow-On
November 2023
UNDISCLOSED
Financial Advisor
Prepackaged Chapter 11 Financial Restructuring and RSA with Stakeholders including Stonepeak
Pending
$236 Million
Joint Global Coordinator and Bookrunner
U.S. Initial Public Offering
October 2023
$225 Million
Joint Bookrunner
Follow-On
October 2023